Scott Alexander examines how compounding pharmacies are producing cheaper versions of GLP-1 agonist drugs, exploring the economics, safety, and future implications of this practice.

Scott Alexander examines the current research on Long COVID, analyzing its prevalence, symptoms, and potential impacts to assess personal risk and societal implications.

Scott Alexander discusses various aspects of the COVID-19 pandemic, including strategies, mysteries, controversies, and global impacts.

This post examines the pros and cons of using gene editing technologies in humans, discussing scientific, medical, and ethical considerations.

Scott Alexander follows up on his critique of a book about the Baumol effect, presenting data that challenges the book's claims about rising wages driving cost increases in education and healthcare.

Scott Alexander shares a diverse collection of links on topics including architecture, history, science, politics, and economics, offering brief commentaries and insights on each.

Scott Alexander criticizes branded combination nootropics, explaining why they are often ineffective or harmful, and advises careful individual experimentation with single substances instead.

A monthly links post collecting and commenting on various interesting articles and studies from around the web, ranging from scientific research to philosophy to economics.

Scott shares and comments on various interesting links, ranging from charity history and religious debates to scientific discoveries and technological developments.

Scott Alexander announces the launch of MetaMed, a company offering personalized medical research, and describes his positive experiences with their rational approach to medical questions.